SCHEMBL7733506

SCHEMBL7733506

C=C(NC(C)=O)c1ccc(C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
GAA P10253 1/20 0.48
LMNA P02545 3/20 0.48
CES2 O00748 3/20 0.48
CES1 P23141 3/20 0.48
TDP1 Q9NUW8 5/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 3/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.46
NPC1 O15118 5/20 0.44
RAB9A P51151 5/20 0.44
PKM P14618 2/20 0.43
HTT P42858 2/20 0.43
ATM Q13315 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HPGD P15428 1/20 0.43
NLRP1 Q9C000 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19435693 0.85 MAPT (0.45) ALDH1A1GAALMNATDP1MEN1
SCHEMBL19724896 0.83 CA1 (0.47) ALDH1A1LMNAMEN1KMT2AMAPT
SCHEMBL19435712 0.82 TPMT (0.45) ALDH1A1GAALMNAMEN1KMT2A
SCHEMBL27568390 0.82 CES2 (0.46) ALDH1A1CES2CES1MEN1KMT2A
SCHEMBL6294231 0.82 EPHX1 (0.49) ALDH1A1LMNACES2CES1MEN1
SCHEMBL14537184 0.82 ALDH1A1 (0.53) ALDH1A1GAALMNACES2CES1
SCHEMBL979427 0.81 CES1 (0.46) ALDH1A1GAALMNACES2CES1
SCHEMBL19435797 0.80 SMN1; SMN2 (0.55) ALDH1A1TDP1MEN1KMT2AMAPT
SCHEMBL19454923 0.80 CA1 (0.53) ALDH1A1TDP1MEN1KMT2AMAPT
SCHEMBL28231692 0.79 TPMT (0.46) GAATDP1MEN1KMT2AHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111747904-A Polyfluoroalkenyl substituted oxazole compound and preparation method thereof 南京工业大学 2020-10-09 CN claimed
CN-120004780-A Method for synthesizing polysubstituted pyrrole compound by taking difluoro cyclopropane as raw material 平顶山学院 2025-05-16 CN disclosed
CN-115043752-A Beta, beta-dibromo enamide and preparation method thereof 天津中医药大学 2022-09-13 CN disclosed
CN-113480533-B Preparation method of 3, 4-pyridine diimides derivatives 赣南师范大学 2022-08-02 CN disclosed
CN-111620832-B Multi-substituted oxazoline compound and preparation method thereof 南京工业大学 2022-07-05 CN disclosed
CN-113480533-A Preparation method of 3, 4-pyridine diimides derivatives 赣南师范大学 2021-10-08 CN disclosed
CN-111747904-A Polyfluoroalkenyl substituted oxazole compound and preparation method thereof 南京工业大学 2020-10-09 CN disclosed
CN-111620832-A Multi-substituted oxazoline compound and preparation method thereof 南京工业大学 2020-09-04 CN disclosed
CN-110156668-A A method of synthesis 4- Polyfluoroalkyl -2,6- diaryl substituted pyridine compound 福州大学 2019-08-23 CN disclosed
CN-109942497-A Polysubstituted pyrimidone compound and preparation method thereof 南京工业大学 2019-06-28 CN disclosed
CN-106146543-B Transition metal complex, chiral alpha-amido three-level borate and preparation method thereof 中国科学院上海有机化学研究所 2018-07-10 CN disclosed
US-20170291885-A1 METHOD FOR PREPARING ENAMIDE COMPOUND AND RUTHENIUM COMPLEX CATALYST USED THEREIN POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) 2017-10-12 US disclosed
US-20170291885-A1 METHOD FOR PREPARING ENAMIDE COMPOUND AND RUTHENIUM COMPLEX CATALYST USED THEREIN POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) 2017-10-12 US disclosed
US-20170291885-A1 METHOD FOR PREPARING ENAMIDE COMPOUND AND RUTHENIUM COMPLEX CATALYST USED THEREIN POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) 2017-10-12 US disclosed
CN-106146543-A Transition metal complex, three grades of borates of chirality alpha-amido and preparation method thereof 中国科学院上海有机化学研究所 2016-11-23 CN disclosed
US-6399787-B1 TRANSITION METAL COMPLEX PENN STATE RESEARCH FOUNDATION 2002-06-04 US disclosed
WO-1999059721-A1 CATALYTIC ASYMMETRIC HYDROGENATION, HYDROFORMYLATION, AND HYDROVINYLATION VIA TRANSITION METAL CATALYSTS WITH PHOSPHINES AND PHOSPHITES THE PENN STATE RESEARCH FOUNDATION (US) 1999-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170291885-A1 METHOD FOR PREPARING ENAMIDE COMPOUND AND RUTHENIUM COMPLEX CATALYST USED THEREIN ENY2, ENO1, IDH1 ALDH1A1 1341/4885GAA 1856/4885LMNA 1300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.